Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes
Authors
Keywords
-
Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume 26, Issue 10, Pages 1391-1398
Publisher
SAGE Publications
Online
2012-07-24
DOI
10.1177/0269881112454229
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- P.6.b.009 Deletion of cannabinoid receptor 2 increased ethanol abuse vulnerability associated to alterations in m-opioid receptor gene expression in mice
- (2011) A. Ortega-Alvaro et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Mechanisms of antidepressant action: An integrated dopaminergic perspective
- (2011) S. Porcelli et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes
- (2011) Antonio Drago et al. PROGRESS IN NEUROBIOLOGY
- Personalized medicine can pave the way for the safe use of CB1 receptor antagonists
- (2011) Judit Lazary et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Genes, Environment, and Individual Differences in Responding to Treatment for Depression
- (2011) Rudolf Uher HARVARD REVIEW OF PSYCHIATRY
- Using gene–environment interactions to target personalized treatment in mood disorder
- (2010) Torsten Klengel et al. Personalized Medicine
- Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression
- (2010) Palmiero Monteleone et al. PHARMACOLOGICAL RESEARCH
- Does the Duration of Index Episode Affect the Treatment Outcome of Major Depressive Disorder?
- (2009) William S. Gilmer et al. JOURNAL OF CLINICAL PSYCHIATRY
- Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients
- (2009) M. Vermeiden et al. JOURNAL OF PSYCHOPHARMACOLOGY
- CNR1 Gene is Associated with High Neuroticism and Low Agreeableness and Interacts with Recent Negative Life Events to Predict Current Depressive Symptoms
- (2009) Gabriella Juhasz et al. NEUROPSYCHOPHARMACOLOGY
- Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors
- (2009) Bárbara Arias et al. Pharmacogenetics and Genomics
- Pharmacogenomics of antidepressant drugs
- (2009) Sonja Horstmann et al. PHARMACOLOGY & THERAPEUTICS
- Cannabinoid receptor 1 (CNR1) gene: Impact on antidepressant treatment response and emotion processing in Major Depression
- (2008) Katharina Domschke et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei
- (2008) Juan Suárez et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain
- (2008) I. Racz et al. JOURNAL OF NEUROSCIENCE
- Interferon- Is a Critical Modulator of CB2 Cannabinoid Receptor Signaling during Neuropathic Pain
- (2008) I. Racz et al. JOURNAL OF NEUROSCIENCE
- Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
- (2008) M Kato et al. MOLECULAR PSYCHIATRY
- Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects
- (2008) Emmanuel S. Onaivi et al. PLoS One
- Pharmacogenetics in Psychiatry: Are We Ready for Widespread Clinical Use?
- (2008) M. J. Arranz et al. SCHIZOPHRENIA BULLETIN
- CB1-cannabinoid receptors are involved in the modulation of non-synaptic [3H]serotonin release from the rat hippocampus
- (2007) Tamás Balázsa et al. NEUROCHEMISTRY INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started